{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:00:14Z","timestamp":1781974814541,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/igc.0b013e31827de6b9","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T12:55:46Z","timestamp":1359118546000},"page":"268-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium\u2014OVCAD"],"prefix":"10.1016","volume":"23","author":[{"given":"Radoslav","family":"Chekerov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Cacsire","family":"Castillo-Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Cadron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"Woelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Marth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Speiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zeillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31827de6b9_bb0005","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/mdq244","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Colombo","year":"2010","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ijgc-00009577-200511001-00004","article-title":"Standard treatment in advanced ovarian cancer in 2005: the state of the art","volume":"15","author":"Bookman","year":"2005","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1525-1438.2007.01161.x","article-title":"Second-line randomized trials in epithelial ovarian cancer","volume":"18","author":"Vermorken","year":"2008","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0030","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1200\/JCO.2007.15.1258","article-title":"Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group","volume":"26","author":"Sehouli","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0035","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/ijc.21599","article-title":"Molecular profiling of platinum resistant ovarian cancer","volume":"118","author":"Helleman","year":"2006","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0040","first-page":"1093","article-title":"Detection of epithelial carcinoma cells in the blood of patients with gynaecological malignancies","volume":"23","author":"Sehouli","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/ijgc-00009577-200311001-00016","article-title":"Translational research in ovarian cancer: a must","volume":"13","author":"Hamilton","year":"2003","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0050","article-title":"OVCADV\u201cOvarian Cancer: Diagnosis of a silent killer\u201d. A Sixth Framework Programme (FP6) Project of the European Research","author":"Zeillinger","year":"2005","journal-title":"Area"},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3233\/CBM-2011-0183","article-title":"Issues in collecting, processing and storing human tissues and associated information to support biomedical research","volume":"9","author":"Grizzle","year":"2011","journal-title":"Cancer Biomark."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2003-41864","article-title":"\u201cIMO\u201d\u2014intraoperative mapping of ovarian cancer [article in German]","volume":"125","author":"Sehouli","year":"2003","journal-title":"Zentralbl Gynakol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0065","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/cncr.11345","article-title":"Pathology and classification of ovarian tumors","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0070","first-page":"576","article-title":"Importance of histologic grading in the prognosis of epithelial ovarian carcinoma","volume":"59","author":"Sorbe","year":"1982","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0075","first-page":"419","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). IntJ Gynecol","volume":"21","author":"Rustin","year":"2011","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ygyno.2010.01.048","article-title":"Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies","volume":"117","author":"Darcy","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-5876-1-2","article-title":"Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms","volume":"1","author":"Lehmann","year":"2003","journal-title":"J Transl Med."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2006.08.001","article-title":"Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer","volume":"102","author":"Vergote","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.21652","article-title":"Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients","volume":"102","author":"Sehouli","year":"2010","journal-title":"J Surg Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"Du Bois","year":"2009","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ijgc-00009577-200503000-00001","article-title":"Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer","volume":"15","author":"Du Bois","year":"2005","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/IGC.0b013e3181bffb3f","article-title":"Prognostic factors for complete debulking in first- and second-line ovarian cancer","volume":"19","author":"Harter","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejso.2010.06.006","article-title":"Patterns of care in surgery for ovarian cancer in Europe","volume":"36","author":"Verleye","year":"2010","journal-title":"Eur J Surg Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-11-69","article-title":"Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancerVa study of the OVCAD consortium","volume":"11","author":"Aust","year":"2012","journal-title":"Mol Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0135","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/ijc.27329","article-title":"Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer","volume":"131","author":"Marme","year":"2012","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significanceVa study of the OVCAD consortium","volume":"128","author":"Obermayr","year":"2012","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0145","first-page":"380","article-title":"Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium","volume":"22","author":"Pils","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1097\/IGC.0b013e31827de6b9_bb0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/IGC.0b013e31823de6ae","article-title":"Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data","volume":"22","author":"Polterauer","year":"2012","journal-title":"IntJ Gynecol Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.lww.com\/ijgc\/Fulltext\/10.1097\/IGC.0b013e31827de6b9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:21Z","timestamp":1753233201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24018620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1048891X24018620"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31827de6b9","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium\u2014OVCAD","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31827de6b9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}